Back to today’s briefing

Story perspectives

UC San Diego's Virus Discovery Sparks Cancer Immunotherapy Hope

7/26/2025

28 6

Summary

Researchers Unveil Cancer Immunotherapy

Researchers at UC San Diego have unveiled a groundbreaking discovery: the cowpea mosaic virus (CPMV) can activate the immune system to combat cancer effectively. This low-cost immunotherapy not only prompts a robust immune response but also recruits diverse immune cells, creating lasting tumor-fighting memory. Excitingly, the team is now pushing CPMV closer to clinical trials.

Summary

Researchers Identify Biomarkers

A groundbreaking AI tool, BioMapAI, created by researchers at The Jackson Laboratory and Duke University, identifies biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) with an impressive 90% accuracy. This innovative study uncovers critical disruptions in the gut microbiome, immune system, and metabolism, offering hope for better diagnosis and treatment for ME/CFS and long COVID.

1 of 2

Researchers Unveil Cancer Immunotherapy

Researchers at UC San Diego have unveiled a groundbreaking discovery: the cowpea mosaic virus (CPMV) can activate the immune system to combat cancer effectively. This low-cost immunotherapy not only prompts a robust immune response but also recruits diverse immune cells, creating lasting tumor-fighting memory. Excitingly, the team is now pushing CPMV closer to clinical trials.

1 / 2